Success Story: NIW Approved for a Cancer Researcher Advancing Head and Neck Cancer Therapies and Regenerative Medicine

Client’s Testimonial:

 

"Really appreciate your support and help!”

 


 

On June 23rd, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Postdoctoral Scholar in the Field of Cancer Research (Approval Notice).

 


 

General Field: Cancer Research

 

Position at the Time of Case Filing: Postdoctoral Scholar

 

Country of Origin: Taiwan

 

Approval Notice Date: June 23rd, 2026

 

Processing Time: 18 months, 25 days (Premium Processing Upgrade Requested)

 


 

Case Summary:

 

Advancing cancer care increasingly depends on research that can identify disease mechanisms, improve therapeutic strategies, and develop innovative materials that support better patient outcomes. The client’s research operates at the intersection of cancer research, stem cell biology, biomaterials, and regenerative medicine, focusing on novel therapies for head and neck cancers and innovative dental materials that may improve therapeutic effectiveness and clinical outcomes.

 

At the time of filing, the client, who received a Ph.D. in oral biology, was conducting cancer research as a postdoctoral scholar at a U.S. research institution. The proposed endeavor focused on advancing cancer and stem cell biology by designing novel therapies for head and neck cancers and developing innovative dental materials to reduce cancer mortality rates, improve treatment outcomes, and support regenerative medicine.

 

For National Interest Waiver petitions, the strongest cases demonstrate not only that a proposed endeavor serves an important national objective, but also that the researcher has already established a record showing the ability to advance that objective. North America Immigration Law Group (NAILG) structured the petition around exactly those considerations, demonstrating that the client’s contributions to cancer progression, treatment resistance, cancer prevention, and biomaterial innovation had already influenced researchers working on head and neck cancer, oral cancer, regenerative medicine, and dental material applications.

 

NAILG organized the evidence so USCIS could evaluate the impact through clear, objective indicators:

 

  • Publication record: 3 peer-reviewed journal articles, including 1 first-authored article, and 2 conference abstracts, 1 first-authored abstract.

 

  • Citation reliance: cited 55 times by researchers in the field.

 

  • Citation distinction: 2 papers ranked among the top 20% most-cited Clinical Medicine articles for their publication years.

 

USCIS approved the I-140 National Interest Waiver petition, recognizing a record defined by focused scholarly productivity, independent reliance by other researchers, and contributions to nationally important biomedical research. We congratulate the client on this achievement and look forward to the continued impact of the client’s work in advancing head and neck cancer therapies, regenerative medicine, and innovative dental materials in the United States.